A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Name: A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
License: Public Domain

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

liver cancer (fibrolamellar hepatocellular cancer (flc))

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 363604
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.